---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277918287.md"
description: "FOSUN PHARMA: Subsidiary HLX97 approved for clinical trials for the treatment of advanced/metastatic solid tumors"
datetime: "2026-03-05T10:24:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277918287.md)
  - [en](https://longbridge.com/en/news/277918287.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277918287.md)
---

# 

FOSUN PHARMA: The clinical trial of its subsidiary HLX97 for the treatment of advanced/metastatic solid tumors has been approved

### Related Stocks

- [02196.HK](https://longbridge.com/en/quote/02196.HK.md)
- [600196.CN](https://longbridge.com/en/quote/600196.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [516610.CN](https://longbridge.com/en/quote/516610.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)

## Related News & Research

- [Fosun Pharma Unit Gets China Nod for Amyloidosis Drug Trial](https://longbridge.com/en/news/282675084.md)
- [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)
- [CSPC wins China trial approval for SYS6051 in advanced solid tumors](https://longbridge.com/en/news/282818199.md)
- [AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid](https://longbridge.com/en/news/282533515.md)
- [Junshi Biosciences schedules board meeting to review Q1 results](https://longbridge.com/en/news/282823588.md)